• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines

tetano

Editor, Senior Moderator
J Prev Med Hyg. 2016 Sep;57(3):E115-E120.
[h=1]History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines.[/h] Barberis I[SUP]1[/SUP], Myles P[SUP]2[/SUP], Ault SK[SUP]3[/SUP], Bragazzi NL[SUP]1[/SUP], Martini M[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza is a highly infectious airborne disease with an important epidemiological and societal burden; annual epidemics and pandemics have occurred since ancient times, causing tens of millions of deaths. A hundred years after this virus was first isolated, influenza vaccines are an important influenza prevention strategy and the preparations used display good safety and tolerability profiles. Innovative tools, such as recombinant technologies and intra-dermal devices, are currently being investigated in order to improve the immunological response. The recurring mutations of influenza strains has prompted the recent introduction of a quadrivalent inactivated vaccine. In the near future, scientific research will strive to produce a long-lasting universal vaccine containing an antigen that will offer protection against all influenza virus strains.


[h=4]KEYWORDS:[/h] History of medicine; Influenza; Vaccination

PMID: 27980374
[PubMed - in process]
 
Back
Top Bottom